【CITIC Pharmaceutical】China Resources Double Crane: Plans to acquire 23.5% of Lier Chemical for 5.656 billion yuan in cash, helping build a benchmark enterprise for synthetic biology

English summary

Event: The company issued the "Major Asset Purchase Plan", intending to acquire a total of 188,102,749 shares of Lier Chemical (002258.SZ) (accounting for 23.50% of Lier Chemical's total share capital) in cash from Sichuan Jiuyuan Investment Holding Group Co., Ltd. (transferring 20%) and Sichuan Huacai Technology Co., Ltd. (transferring 3.5%). After the transaction, Lier Chemical's controlling shareholder will change from Jiuyuan Group to China Resources Double Crane, and the actual controller will change to China Resources. Transaction price: The proposed transfer price is 30.07 yuan per share, corresponding to a total price of approximately 5.656 billion yuan (of which Jiuyuan Group approximately 4.814 billion yuan, Huacai Technology approximately 842 million yuan). If ex-rights and ex-dividend events such as bonus shares, capital reserve conversion, rights issue, or cash dividends occur between the agreement signing and the transfer, the number of shares and unit price will be adjusted accordingly (dividends declared before signing will not be adjusted). The final valuation is subject to board, shareholders' meeting, and relevant state-owned assets department approval after evaluation/valuation is completed. ...